• For Institutions

  • Download
  • Help
  • About

longbridgelongbridge
longbridgelongbridge
Products
Pricing
Markets
Global Markets
Stock Screener
Information
Insights
News
Live
Academy
Affiliate Program
Promotions
PortAI
EN
English
简体中文
繁體中文
繁體中文(廣東話)Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List
Overview
News
Financials
© 2025 Longbridge|Disclaimer

Event Tracking

Dec12
Wells Fargo Upgrades Celcuity to Outperform with $126 Price Target
20:07
Dec11
Celcuity Inc. Announces Positive Phase 3 Clinical Trial Results for Gedatolisib in Breast Cancer
19:35
Dec9
Celcuity Inc. Director Sells Common Stock
21:24
Nov26
Celcuity Announces Results of Phase III Trial for Gedatolisib
21:05
Nov25
Celcuity Shares Reach a 52-Week High With Earnings Exceeding Expectations
23:25
Nov24
Celcuity Inc. Director David Dalvey Sells Common Stock
21:07

Schedules & Filings

Schedules
Filings
Nov12
Earning Release(EST)

FY2025 Q3 Earning Release (USD) Net Income -43.8 M, EPS -0.9204

Aug14
Earning Release(EST)

FY2025 Q2 Earning Release (USD) Net Income -45.27 M, EPS -1.0367

May14
Earning Release(EST)

FY2025 Q1 Earning Release (USD) Net Income -37 M, EPS -0.8593

View More

Stock List

Top Gainers
Top Decliners
China Concepts
Symbol
Price
%Chg
Change
MSOX
7.940
+107.85%
+4.120
YCBD
1.200
+90.17%
+0.569
THH
15.520
+57.72%
+5.680
WEED
25.325
+55.65%
+9.055
NCI
1.920
+54.84%
+0.680
CNBS
34.820
+54.57%
+12.293
MSOS
5.800
+54.26%
+2.040
CGC
1.740
+53.98%
+0.610
RYM
23.800
+47.73%
+7.690
TLRY
12.150
+44.13%
+3.720
View More